JP2002513761A5 - - Google Patents

Download PDF

Info

Publication number
JP2002513761A5
JP2002513761A5 JP2000546777A JP2000546777A JP2002513761A5 JP 2002513761 A5 JP2002513761 A5 JP 2002513761A5 JP 2000546777 A JP2000546777 A JP 2000546777A JP 2000546777 A JP2000546777 A JP 2000546777A JP 2002513761 A5 JP2002513761 A5 JP 2002513761A5
Authority
JP
Japan
Prior art keywords
dioxoethyl
spla
overproduction
phenylmethyl
indol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000546777A
Other languages
English (en)
Japanese (ja)
Other versions
JP4459441B2 (ja
JP2002513761A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US1999/008538 external-priority patent/WO1999056752A1/en
Publication of JP2002513761A publication Critical patent/JP2002513761A/ja
Publication of JP2002513761A5 publication Critical patent/JP2002513761A5/ja
Application granted granted Critical
Publication of JP4459441B2 publication Critical patent/JP4459441B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2000546777A 1998-05-01 1999-04-20 sPLA2阻害剤エステル Expired - Fee Related JP4459441B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8387398P 1998-05-01 1998-05-01
US60/083,873 1998-05-01
PCT/US1999/008538 WO1999056752A1 (en) 1998-05-01 1999-04-20 sPLA2 INHIBITOR ESTER

Publications (3)

Publication Number Publication Date
JP2002513761A JP2002513761A (ja) 2002-05-14
JP2002513761A5 true JP2002513761A5 (cg-RX-API-DMAC10.html) 2006-06-22
JP4459441B2 JP4459441B2 (ja) 2010-04-28

Family

ID=22181214

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000546777A Expired - Fee Related JP4459441B2 (ja) 1998-05-01 1999-04-20 sPLA2阻害剤エステル

Country Status (22)

Country Link
EP (1) EP1073440B1 (cg-RX-API-DMAC10.html)
JP (1) JP4459441B2 (cg-RX-API-DMAC10.html)
KR (1) KR20010071197A (cg-RX-API-DMAC10.html)
CN (1) CN1303290A (cg-RX-API-DMAC10.html)
AT (1) ATE280155T1 (cg-RX-API-DMAC10.html)
AU (1) AU755901B2 (cg-RX-API-DMAC10.html)
BR (1) BR9910149A (cg-RX-API-DMAC10.html)
CA (1) CA2331036A1 (cg-RX-API-DMAC10.html)
DE (1) DE69921314T2 (cg-RX-API-DMAC10.html)
EA (1) EA003277B1 (cg-RX-API-DMAC10.html)
ES (1) ES2230847T3 (cg-RX-API-DMAC10.html)
HR (1) HRP20000738A2 (cg-RX-API-DMAC10.html)
HU (1) HUP0201636A1 (cg-RX-API-DMAC10.html)
ID (1) ID27812A (cg-RX-API-DMAC10.html)
IL (1) IL139203A0 (cg-RX-API-DMAC10.html)
NO (1) NO315940B1 (cg-RX-API-DMAC10.html)
NZ (1) NZ507391A (cg-RX-API-DMAC10.html)
PL (1) PL344571A1 (cg-RX-API-DMAC10.html)
SK (1) SK16332000A3 (cg-RX-API-DMAC10.html)
TR (1) TR200003198T2 (cg-RX-API-DMAC10.html)
WO (1) WO1999056752A1 (cg-RX-API-DMAC10.html)
ZA (1) ZA200005561B (cg-RX-API-DMAC10.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6140327A (en) * 1999-05-12 2000-10-31 Eli Lilly And Company Morpholino-n-ethyl ester derivative of an indole sPLA2 inhibitor
WO2001044185A1 (en) * 1999-12-16 2001-06-21 Eli Lilly And Company Carbon monoxide-based synthesis of spla2 inhibitors
DE19962300A1 (de) * 1999-12-23 2001-06-28 Asta Medica Ag Substituierte N-Benzyl-Indol-3-yl-glyoxylsäure-Derivate mit Antitumorwirkung
CN1450893A (zh) * 2000-07-14 2003-10-22 伊莱利利公司 治疗脓毒症的方法
EP2154958A4 (en) * 2007-05-03 2011-05-04 Anthera Pharmaceuticals Inc TREATMENT OF HEART CIRCULATION DISEASES AND DYSLIPIDEMIA WITH INHIBITORS OF SECRETARY PHOSPHOLIPASE A2 (SPLA2) AND SPLA2 HEMMER COMBINATION THERAPIES
US8048880B2 (en) 2007-05-03 2011-11-01 Anthera Pharmaceuticals, Inc. Treatment of cardiovascular disease and dyslipidemia using secretory phospholipase A2 (SPLA2) inhibitors and SPLA2 inhibitor combination therapies
US20150335498A1 (en) * 2014-05-22 2015-11-26 The Procter & Gamble Company Heterogenous mass containing foam
US10729600B2 (en) 2015-06-30 2020-08-04 The Procter & Gamble Company Absorbent structure
PL3370664T3 (pl) 2015-11-04 2022-03-07 The Procter & Gamble Company Wyrób chłonny zawierający strukturę chłonną
WO2017079599A1 (en) 2015-11-04 2017-05-11 The Procter & Gamble Company Absorbent structure
WO2017079605A1 (en) 2015-11-04 2017-05-11 The Procter & Gamble Company Method for determining bunch compression

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2036307C (en) * 1990-03-08 2002-07-09 Susan Jean Ward 3-arylcarbonyl-1-aminoalkyl-1h-indole-containing antiglaucoma compositions and method
EP1950200B1 (en) * 1994-04-01 2012-01-11 Eli Lilly And Company [[3-(2-amino-1,2-dioxoethyl)-2-ethyl-1-(phenylmethyl)-11H-indol-4-yl]oxy]acetic acid methyl ester as sPLA2 inhibitor
DE4435477A1 (de) * 1994-10-04 1996-04-11 Bayer Ag Cycloalkano-indol- und -azaindol-derivate
US6297269B1 (en) * 1995-06-06 2001-10-02 Pfizer Inc. Substituted n-(indole-2-carbonyl-) amides and derivatives as glycogen phosphorylase inhibitors
CA2358492A1 (en) * 1998-12-21 2000-06-29 Eli Lilly And Company Combination therapy for the treatment of sepsis

Similar Documents

Publication Publication Date Title
JP2001520998A5 (cg-RX-API-DMAC10.html)
DK1950200T3 (da) [[3-(2-AMINO-1,2-DIOXOETHYL)-2-ETHYL-1-(PHENYLMETHYL)-11H-INDOL-4-YL]OXY]EDDIKESYREMETHYLESTER SOM sPLA2-INHIBITOR
JP2002518502A5 (cg-RX-API-DMAC10.html)
CA2445145A1 (en) Carboxylic acid substituted oxazole derivatives for use as ppar-alpha and -gamma activators in the treatment of diabetes
ATE293443T1 (de) Medikament zur behandlung chronisch obstruktiver lungenerkrankung
NO20071577L (no) Bifenyloksyiddiksyrederivater for behandling av luftveissykdommer
JP2002501025A5 (cg-RX-API-DMAC10.html)
JP2008518890A5 (cg-RX-API-DMAC10.html)
CA2472954A1 (en) Aza-arylpiperazines
JP2003503449A5 (cg-RX-API-DMAC10.html)
PL377478A1 (pl) Cykloalkenowe kwasy dikarboksylowe jako środki przeciwzapalne, immunomodulujące oraz antyproliferacyjne
WO2001000566A3 (en) Substituted phenoxyacetic acids
JP2002520286A5 (cg-RX-API-DMAC10.html)
JP2001520991A5 (cg-RX-API-DMAC10.html)
HUP0102812A3 (en) Pharmaceutical compositions containing the phospholipase inhibitor sodium {[3-(2-amino-1,2-dioxoethyl)-2-ethyl-1-(phenylmethyl)-1h-indol-4-yl]oxy}acetate and process for pruducing them
NO20005477L (no) sPLA2-hemmende ester
JP2008514558A5 (cg-RX-API-DMAC10.html)
WO2001019819A3 (en) Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment
EP1253139A3 (en) Multioligoanilinated fullerenes
WO2004048381A3 (en) Pyrazoloazepine compounds as pharmaceutical agents
EP1226819A4 (en) INHIBITORS FOR THE 20-HETE-PRODUCING ENZYME
JP2001294524A5 (cg-RX-API-DMAC10.html)
WO2006033505A8 (en) Paroxetine cholate or cholic acid derivative salts, and composition comprising paroxetine and cholic acid or cholic acid derivatives
AU2129800A (en) Improved process for the preparation of benzenesulfonylureas as oral hypoglycemic agents of the second generation
AU3606100A (en) Methods for administering pharmacologically active compounds to vertebrates